These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 32522146

  • 21. High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study.
    May HT, Knowlton KU, Anderson JL, Lappé DL, Bair TL, Muhlestein JB.
    Eur Heart J Qual Care Clin Outcomes; 2022 May 05; 8(3):352-360. PubMed ID: 33787865
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z, Mohan A, Paranjpe R, Abughosh SM.
    J Manag Care Spec Pharm; 2021 Feb 05; 27(2):186-197. PubMed ID: 33506725
    [Abstract] [Full Text] [Related]

  • 26. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
    Mahtta D, Ahmed ST, Ramsey DJ, Akeroyd JM, Lee MT, Rodriguez F, Michos ED, Itchhaporia D, Nasir K, Alam M, Jneid H, Ballantyne CM, Petersen LA, Virani SS.
    Cardiovasc Drugs Ther; 2020 Dec 05; 34(6):745-754. PubMed ID: 32840709
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    JACC Cardiovasc Imaging; 2017 Feb 05; 10(2):143-153. PubMed ID: 27665163
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Adherence to statins in primary prevention: yearly adherence changes and outcomes.
    Slejko JF, Ho M, Anderson HD, Nair KV, Sullivan PW, Campbell JD.
    J Manag Care Pharm; 2014 Jan 05; 20(1):51-7. PubMed ID: 24372460
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.
    Yew PY, Loth M, Adam TJ, Wolfson J, Liang Y, Tonellato PJ, Chi CL.
    BMC Cardiovasc Disord; 2024 May 10; 24(1):245. PubMed ID: 38730371
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.
    Gelbenegger G, Postula M, Pecen L, Halvorsen S, Lesiak M, Schoergenhofer C, Jilma B, Hengstenberg C, Siller-Matula JM.
    BMC Med; 2019 Nov 04; 17(1):198. PubMed ID: 31679516
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
    Corrao G, Scotti L, Zambon A, Baio G, Nicotra F, Conti V, Capri S, Tragni E, Merlino L, Catapano AL, Mancia G.
    Atherosclerosis; 2011 Aug 04; 217(2):479-85. PubMed ID: 21592477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.